1. Home
  2. CDT vs IMTE Comparison

CDT vs IMTE Comparison

Compare CDT & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$1.22

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Logo Integrated Media Technology Limited

IMTE

Integrated Media Technology Limited

HOLD

Current Price

$0.96

Market Cap

2.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDT
IMTE
Founded
2019
2008
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
2.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDT
IMTE
Price
$1.22
$0.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
113.0K
1.7M
Earning Date
11-13-2025
09-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$123,337.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.75
52 Week Low
$1.20
$0.50
52 Week High
$700.68
$3.17

Technical Indicators

Market Signals
Indicator
CDT
IMTE
Relative Strength Index (RSI) 34.45 70.28
Support Level $1.30 $0.53
Resistance Level $1.59 $1.07
Average True Range (ATR) 0.12 0.12
MACD 0.00 0.05
Stochastic Oscillator 1.28 77.37

Price Performance

Historical Comparison
CDT
IMTE

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: